On 25 September, a report on "Future-Proofing the Alzheimer’s Disease Healthcare Journey: Emerging Best Practices Across Europe" was published by the European Federation of Pharmaceutical Industries and Associations (EFPIA). This new report highlights effective, scalable solutions in Alzheimer's disease detection, diagnosis and care across Europe. Produced by Shift Health with funding from the EFPIA Alzheimer’s disease Platform, it examines emerging best practices in eight countries: Czechia, France, Germany, Netherlands, Poland, Slovenia, Spain and Sweden.
You can download the report, here: https://www.efpia.eu/media/fs1bspuw/future-proofing-the-ad-healthcare-journey.pdf